Clinical outcomes of relapsed/refractory multiple myeloma patients after BCMA-targeted CAR T therapy

OncoAlert and ecancer weekly round up for August 23rd - August 29th, 2021

OncoAlert and ecancer weekly round up for July 26 - August 1, 2021

OncoAlert and ecancer weekly round up for July 12- July 18, 2021

ASCO 2021: Precision and molecular reporting for prostate cancer

Neo-AEGIS: Preliminary results of phase III RCT of CROSS versus perioperative chemotherapy

PrE0807: Neoadjuvant nivolumab without or with lirilumab in cisplatin-ineligible patients with muscle-invasive bladder cancer

Efficacy and safety of tisagenlecleucel in adult patients with relapsed/refractory follicular lymphoma

AL3818 hydrochloride monotherapy in subjects with metastatic or advanced synovial sarcoma

Afamitresgene autoleucel (Formerly ADP-A2M4) in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma

Adjuvant chemo following chemoradiation as treatment for locally advanced cervical cancer compared to chemoradiation alone

HCRN GU 16-257: Phase 2 trial of gemcitabine, cisplatin, plus nivolumab with selective bladder sparing in MIBC patients